Application 013025
- Type
- NDA
- Sponsor
- HOSPIRA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | THAM-E | POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE | INJECTABLE;INJECTION | 370MG/VIAL;1.75GM/VIAL;36GM/VIAL | No | No |
| 002 | THAM | TROMETHAMINE | INJECTABLE;INJECTION | 3.6GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-1593 | THAM | TROMETHAMINE | Hospira, Inc. | NDA | Current |